EDGE
Get a demo
Log In

HaploX Biotechnology

HaploX is a biotechnology company that aims to improve cancer patient management by integrating liquid biopsy technology, gene sequencing, artificial intelligence, big data, and other technologies. Its technologies include tools for extracting and amplifying ultra-low concentrations of DNA from liquid samples, performing tagged sequencing, and managing and analyzing the resulting data.

Company Brief


HQ location:
Shenzhen
Founded year:
2014
Employees:
501 - 1000
Total Funding:
USD 72.2 million

Funding


Investors


No investor data is available

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.